Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in autoimmunity

F M Brennan1, M Feldmann

  • 1Kennedy Institute of Rheumatology, Hammersmith, London, UK. f.brennan@s1.cxwms.ac.uk

Current Opinion in Immunology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.

Rheumatology (Oxford, England)·2008
Same author

Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.

Scandinavian journal of immunology·2008
Same author

The importance of T cell interactions with macrophages in rheumatoid cytokine production.

Current topics in microbiology and immunology·2006
Same author

Planning your research training.

Rheumatology (Oxford, England)·2005
Same author

Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro.

British journal of anaesthesia·2004
Same author

IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis.

Digestive diseases and sciences·2004
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Cytokine research has advanced autoimmune disease understanding. Anti-tumor necrosis factor (TNF) alpha therapy shows significant clinical benefits for rheumatoid arthritis and Crohn

Area of Science:

  • Immunology and molecular biology
  • Autoimmune disease pathogenesis

Background:

  • Cytokines play a crucial role in autoimmune diseases.
  • Rheumatoid arthritis and Crohn's disease are key areas of focus.
  • Anti-tumor necrosis factor (TNF) alpha therapy has emerged as a significant treatment.

Purpose of the Study:

  • To review recent developments in cytokine roles in autoimmune diseases.
  • To highlight the efficacy of anti-TNF alpha therapy.
  • To summarize findings from animal models and clinical trials.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of in vivo studies in animal models of autoimmunity.
  • Evaluation of data from clinical trials.

Related Experiment Videos

Main Results:

  • Anti-TNF alpha therapy demonstrates clinical benefit and reproducible results in rheumatoid arthritis and Crohn's disease.
  • In vivo studies and clinical trials have significantly advanced understanding.

Conclusions:

  • Cytokines are critical targets in autoimmune disease treatment.
  • Anti-TNF alpha therapy represents a successful therapeutic strategy.
  • Continued research in animal models and clinical settings is vital.